Head-to-head comparison of the costs of atypical antipsychotics : A systematic review

In many countries, prescribing guidelines recommend the use of atypical or second-generation antipsychotics (SGAs) in the first-line treatment of individuals with newly diagnosed schizophrenia. This recommendation has increased the utilisation of these agents and, consequently, produced a progressiv...

Ausführliche Beschreibung